🔥off the press: ESMO Open Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer 👏Great consensus with our Asian friends & colleagues 👇my personal link to share: authors.elsevier.com/sd/article/S20… ESMO - Eur. Oncology

In a phase 3 trial (Again and again…) with 560 patients, adding olanzapine to dexamethasone, palonosetron, and aprepitant increased complete response rates from 82% to 91%. 🟠Results suggest olanzapine should be a standard to reduce chemotherapy-induced nausea and vomiting

Curing Stomach Cancer: What Was Debbie's Dream? - Andrea Eidelman Debbie's Dream Foundation: Curing Stomach Cancer Gevorg Tamamyan Immune Oncology Research Institute AACR ASCO ESMO - Eur. Oncology Yelena Y. Janjigian MD oncodaily.com/dialogues/1207… #AACR #ASCO #Cancer #ESMO #GastricCancer #OncoDaily #Oncology #CancerTreatment #StomachCancer

Management of Locally Advanced Rectal Cancer: ASCO Guideline 🔹️Timing of Chemotherapy 🔹️Total Neoadjuvant Therapy 🔹️Nonoperative Management 🔹️Immunotherapy OncoAlert ascopubs.org/doi/10.1200/JC…

Oncoinfluencers to Follow on Social Media: Dr. Karen Knudsen, MBA PhD American Cancer Society American Cancer Society Cancer Action Network oncodaily.com/url/124124 #Oncoinfluencer #ProstateCancer #ASCO #Cancer #Oncology #OncoDaily #CancerPrevention

Leading Oncology Care with Compassion and Innovation - Maite Bourlon The Lancet Conquer Cancer, the ASCO Foundation ASCO Julie Gralow Dirección de Investigación INCMNSZ Dirección de Enseñanza del INCMNSZ oncodaily.com/blog/126038 #Cancer #ConquerCancer #OncoDaily #Oncology #ASCO #TheLancet #CancerCare

Oral Presentation Rubric

📢 Stay up-to-date with the latest in GI oncology! Check out the ESDO Bullets Bulletin for July 2024! esdo.eu/publications-r… my_UEG

📘Targeting HER2-low gastric cancer ESMO Open ✅Clinicopathological differences ✅Available studies and ongoing trials ✅Action mechanisms ✅IHC criteria different from breast cancer 👉doi.org/10.1016/j.esmo… ESMO - Eur. Oncology Kohei shitara OncoAlert #cancer #oncology #MedX

No te pierdas la oportunidad de participar en nuestro Simposio Internacional sobre Cáncer Gastroesofágico "Descifrando el tratamiento" Fecha: viernes 04 de octubre de 2024 Sede: INCan Registro: bit.ly/3Z1ld1I

La Dirección de Docencia y la Sociedad Médica del INCan invitan a la sesión general "Unidad Funcional de Gastroenterología" Fecha: miércoles 28 de agosto de 2024 Hora: 08:30 hrs. Lugar: Auditorio INCan

We’re thrilled to host an international event focused on gastric cancer, bringing together leading experts and groundbreaking discussions! October 4th, 2024 at Instituto Nacional de Cancerología Yelena Y. Janjigian MD Florian Lordick Juan OConnor Marcelo Garrido Diego-Felipe Ballen A.Takahashi MD, MHA

My Top 10 Gastrointestinal Cancer Abstracts #ESMO24 ESMO - Eur. Oncology

📘Current and future treatments of biliary tract cancers ESMO - Eur. Oncology-Gastrointestinal Oncology Journal 👉doi.org/10.1016/j.esmo… Florian Lordick Ben Westphalen Hanneke van Laarhoven Teresa Macarulla OncoAlert #cancer #oncology #MedX

🎙️ OncoDaily Interviews features Dr. Matti Aapro and Dr. Martin Harutyunyan discussing global medical guidelines and adapting anti-emetic guidelines for low-resource settings MASCC 🔗Explore their insights here: oncodaily.com/dialogues/1359…

~1 week to #ESMO24, here is a📝 of 🔑abstracts for general onc that could change/reinforce our SoC! - #NIAGARA - #KN522 - #NATALEE - #DB12 - #MARIPOSA2 - #KRYSTAL12 - #NICHE2 - #SAKK41 - #POD1UM - #KN811 #BCSM #GISM #LCSM #MedTwitter #GUSM #OncTwitter ESMO - Eur. Oncology OncoAlert

🧬Mismatch repair in pancreatic cancer JAMA Oncology ✅Although it is rare, MSI should be tested in pancreatic cancer ✅Median IO duration: 27.7 months, DCR: 80% 👉doi:10.1001/jamaoncol.2024.3651 Catherine O’Connor Emily Harrold Wungki Park, MD MS Eileen M O’Reilly #cancer #Oncology #MedX

Omission of 5-FU Bolus From Multidrug Regimens 🔍Retrospective study with ~12,000 pts in GI cancer 💥Omitting 5-FU bolus had no negative impact on survival (FOLFOX, FOLFIRI, FOLFIRINOX) 💥Associated with a significant reduction in toxicity jnccn.org/view/journals/…

Ponsegromab for the Treatment of Cancer Cachexia NEJM doi.org/10.1056/NEJMoa… 👉Ponsegromab = humanized monoclonal antibody inhibiting GDF-15 👉Weight gain: 1.22 kg (100mg), 1.92 (200 mg), 2.81 (400 mg) 👏very promising effects on tumor cachexia ESMO - Eur. Oncology